CpG oligonucleotides as immune adjuvants

Ernst Schering Res Found Workshop. 2000:(30):105-18. doi: 10.1007/978-3-662-04183-3_7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / genetics
  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • B-Lymphocytes / immunology
  • Base Sequence
  • Cancer Vaccines / genetics
  • Cancer Vaccines / immunology
  • Cancer Vaccines / pharmacology
  • CpG Islands*
  • Cytokines / biosynthesis
  • Humans
  • Mice
  • Neoplasms / immunology
  • Neoplasms / therapy
  • Oligodeoxyribonucleotides / genetics
  • Oligodeoxyribonucleotides / immunology
  • Oligodeoxyribonucleotides / pharmacology*
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology
  • Vaccines, DNA / pharmacology

Substances

  • Adjuvants, Immunologic
  • Cancer Vaccines
  • Cytokines
  • Oligodeoxyribonucleotides
  • Vaccines, DNA